Allogeneic T Cell Therapies and the Challenges of Scaling

This chapter discusses the focus on allogeneic T cell therapies in cancer treatment and the challenges of scaling up these therapies. The speaker emphasizes the need to provide therapies that can be delivered to a large number of patients, are easy to use, and cost-effective. They also discuss the importance of finding the right cell type and utilizing non-viral gene editing technology for allogeneic therapies.